Apollo Hospital unveils first ZAP-X brain tumour treatment in South Asia
ZAP-X gyroscopic radiosurgery platform is designed for the treatment of brain tumours, offering non-invasive, pain-free sessions lasting 30 minutes.
ZAP-X gyroscopic radiosurgery platform is designed for the treatment of brain tumours, offering non-invasive, pain-free sessions lasting 30 minutes.
The innovation segment is dominated by pharma services (CDMO, CRO, pharma IT) and health-tech with vaccines and biotech, and med-tech emerging as green shoots
The stock has maintained an uptrend for the fifth consecutive session and rose 22.5% during this period, while it gained 17% in a month.
Investments rise but companies ask for more hand-holding and incentives to make India a manufacturing base.
Entero Healthcare Solutions plans to raise ₹1,000 crore via fresh issue and ₹600 crore through OFS route
The industry expects an enhanced healthcare spend of 2.5% of GDP to boost infrastructure and R&D activities.
Women occupy only 18% of healthcare leadership positions and continue to earn 34% less than their male counterparts.
The healthcare firm plans to split India and GCC (Gulf Cooperation Council) businesses into separate entities and divest gulf business for $1 billion.
An entrepreneurial mindset, with a will to improve lives, can bring the might of even machine learning and improved diagnostics to everyday medicine.
Mankind Pharma has reported 19.4% YoY rise in profit at ₹501.03 cr in Q2 FY24, while revenue from operations jumped 11.6% to ₹2,708.10 cr.